Pharmaguy's Insights Into Drug Industry News
185.8K views | +17 today
Follow
Pharmaguy's Insights Into Drug Industry News
Pharmaguy curates and provides insights into selected drug industry news and issues.
Curated by Pharma Guy
Your new post is loading...
Your new post is loading...
Scooped by Pharma Guy
Scoop.it!

In a Blow to PhRMA, Only 9% of People in U.S. Rank Pharma as the Most Innovative Industry

In a Blow to PhRMA, Only 9% of People in U.S. Rank Pharma as the Most Innovative Industry | Pharmaguy's Insights Into Drug Industry News | Scoop.it
Only 17% of consumers polled in the 2017 Klick Health Consumer Survey on Healthcare Innovation currently perceive health-related industries as being the most innovative, out of 18 industries examined. Specifically, pharmaceuticals & biotech, health & wellness, and hospital sectors lagged considerably in perceived innovation behind consumer electronics, telecommunications, and media & entertainment.

However, respondents ranked health & wellness first in terms of the industry that should be the most innovative, quickly followed by pharmaceuticals & biotech, and hospitals in the top five industries. These results suggest a desire by consumers for innovation in healthcare, even though they do not believe that healthcare-related industries are particularly innovative today.
Pharma Guy's insight:

On the bright side, Pharma does rank #4 in a list of 19 industries, most of which no one considers most innovative.

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Insurance is Driving Physicians Mad; Nearly Half Now Say They’d Prefer Single-Payer

Insurance is Driving Physicians Mad; Nearly Half Now Say They’d Prefer Single-Payer | Pharmaguy's Insights Into Drug Industry News | Scoop.it

Nearly half of the 500 doctors who responded to a February LinkedIn survey said they would support a single-payer healthcare system, or Medicare-like coverage for everyone, not just the elderly, instead of the current patchwork model of insurance coverage.

 

The reasons that patients delay care until they can’t wait any longer are complex. But a barrier doctors said they consistently see is a fragmented system: People either don’t have health insurance or can’t find a doctor who accepts their coverage.

 

The physician sentiment comes as Congress is locked in a debate about what to do about the Affordable Care Act. Republicans in the House last week pulled a bill that would have significantly altered the insurance landscape.

 

But for many physicians, the issue comes down to efficiency. In their responses, they cited the administrative hassle of working with multiple insurance companies, each with its own rules and billing procedures. And they pointed to some of the less visible costs, like patients who bounce from one healthcare provider to another as their health plans change.

 

A total of 48% of physicians said they would be in favor of single-payer healthcare, while 32% were opposed and 21% said they didn’t know.

 

Our survey was conducted Feb. 7-19 and reached 511 physicians in the U.S. A total of 449 respondents are currently practicing in patient care. They were chosen at random, and reflect a number of different specialties and years of experience.

 

Further Reading:

  • “Kaiser Poll: 63% Positive About ‘Medicare-for-All’ vs 44% for ‘Single Payer’"; http://sco.lt/5ZAj45
Pharma Guy's insight:

Pharma's strategy to position insurance companies as the culprit causing high drug prices may have backfired if this survey is any indication. 

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Celebrity, Mascot or No, Consumer #Pharma TV Ads Have Little Influence, Survey Says

Celebrity, Mascot or No, Consumer #Pharma TV Ads Have Little Influence, Survey Says | Pharmaguy's Insights Into Drug Industry News | Scoop.it

Treato, the single largest source of online consumer insights on healthcare, released their annual survey on consumers' opinions of DTC advertisements. The survey of more than 500 Treato.com users found that consumers are rarely motivated to take action after seeing an advertisement for a drug on TV. Only seven percent of respondents said they have asked a doctor about a drug after seeing an advertisement about it on TV. This is significantly down from last year's survey in which 21 percent of respondents said that they had asked a doctor about a drug they saw on TV.

 

The Treato.com survey also revealed that consumers aren't easily influenced by celebrities in DTC advertisements as 76 percent of respondents said they are no more inclined to pay attention to a drug advertisement even if it features a celebrity. In addition, animated characters seem to have little influence on consumers as 80 percent of respondents said they are no more inclined to pay attention to a drug advertisement if it features an animated character.

 

"Pharma marketers need to think of more innovative ways to engage directly with health consumers," says Ido Hadari, CEO of Treato. "It's clear that consumers are rarely responsive to the one way communication of TV advertisements."

Pharma Guy's insight:

What! Consumers are not influenced by those cute mascots?! As for celebrities, I always said pharma marketers were wasting money on them. Read, for example, "Your Brand Celebrity Spokespersons Are Worthless!"; http://bit.ly/worthlesscelebs 

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Survey: What's the Future of DTC Advertising?

Survey: What's the Future of DTC Advertising? | Pharmaguy's Insights Into Drug Industry News | Scoop.it

This survey asks your opinion regarding the future of Direct-to-Consumer (DTC) advertising spending, which has surged recently despite the current political climate where DTC drug advertising is being blamed for high drug prices.


But the political climate is not the only factor that may impact DTC spending.

The survey also asks respondents to rate the importance of several factors that influenced their prediction about the future of measured media DTC ad spending.

After completing the survey -- it takes only 5 minutes -- you will be able to see the de-identified results to date.


What's your view?

 

Take the survey here

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

FDA to Launch First Public Survey of DTC Advertising Since 2002

FDA to Launch First Public Survey of DTC Advertising Since 2002 | Pharmaguy's Insights Into Drug Industry News | Scoop.it
Direct-to-consumer (DTC) advertising for pharmaceuticals has been a hot topic recently as federal and state officials have questioned their utility, particularly as the US and New Zealand are the only two countries in the world that have them. Now, the US Food and Drug Administration (FDA) is looking to survey patients about their experiences with DTC drug ads.


The new survey also comes as Rep. Rosa DeLauro (D-CT) has recently introduced a bill that would prohibit all DTC ads for the first three years after a new drug is approved. Physicians at the American Medical Association (AMA) in November also called for a ban on DTC ads for pharmaceuticals. 


Read more about this survey here.

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Patients Drive Treatment Discussions With Doctors More Than Half the Time, According to Inspire's Annual Survey

Patients Drive Treatment Discussions With Doctors More Than Half the Time, According to Inspire's Annual Survey | Pharmaguy's Insights Into Drug Industry News | Scoop.it

Patients are both highly prepared for and engaged in the management of their healthcare, according to a new report by Inspire. 


Inspire, the largest patient engagement platform in the United States, received over 13,000 responses to its online survey, detailed in "Insights from Engaged Patients: An analysis of the inaugural Inspire Survey."


When asked about their preparation for doctor visits, 55% of respondents reported going to their appointments with another person; further, nearly two-thirds of respondents go prepared with notes and/or questions to help guide the in-office discussion, according to Dave Taylor, director of research for Inspire. New treatment discussions are initiated by patients 52% of the time, according to the survey.


"This inaugural report is the first edition of what we hope will become a resource for all the participants in our healthcare system," Inspire CEO Brian Loew said in the report's introduction. 


Other survey results revealed: 


* Half of all patients have experienced difficulties with the affordability of their medications at some point in their life; in fact, cost was the primary reason why affected respondents have gone without a prescribed medication. 


* 72% of U.S.-based patients reported experiencing some increase in their healthcare costs (i.e. insurance premiums, office copays, ancillary treatment costs) while 65% indicated that at least one of their prescription medications was switched to a generic equivalent by their insurance company in an effort to reduce costs. 


* Two-thirds of patients use social networks as a source of information and support for their health conditions. Also, nearly 30% of respondents use smartphone apps to support their healthcare needs, and an additional 43% believe smartphone apps could be helpful for them. 


Inspire is preparing to survey its community again later this year. Inspire's next survey, of 700,000 patients and caregivers, will continue to track healthcare trends and will seek to explore new areas of importance such as precision medicine and shared decision making, according to Taylor.

Pharma Guy's insight:

This is obviously something the pharma industry has know for many years. Practically every DTC communication urges patients to "Ask your physician is BRANDNAME DRUG is right for you" and many campaigns include a list of questions that patients can use to help guide the in-office discussion.

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Pharma's "Minority Report" - Survey Says Pre-Patients Want to Be Warned About Risks

Pharma's "Minority Report" - Survey Says Pre-Patients Want to Be Warned About Risks | Pharmaguy's Insights Into Drug Industry News | Scoop.it

The industry should be doing more to make patients aware of additional health services within their treatment pathways.


This is according a new survey: Patient Services: Pharma's Best Kept Secret, commissioned by Accenture, of 10,000 patients in five countries and across seven therapeutic areas.


It revealed that when patients are aware of additional therapeutic services, nearly six out of 10 of those surveyed use them (58%), and nearly eight in 10 (79%) perceive the services as extremely or very valuable. 


Yet, less than one in five patients (19%) are aware these programmes even exist as pharma is not communicating their existence well enough.


Results show patient awareness is low across all therapeutic areas, ranging from 18% for bones, lung and heart conditions, to 21% for cancer and immune diseases.


The survey also revealed that patients want more help and guidance before they begin treatment for a disease, with their greatest frustration being lack of notification of being “at risk” for a condition. 


Nearly two-thirds of the survey respondents (65%) said that pre-treatment is the most frustrating period of the patient journey, while 34% of patients surveyed cited frustration with the lack of knowledge that they might be at risk of a condition before they experience symptoms. This percentage rose to 44 percent of patients surveyed with immune diseases.

Pharma Guy's insight:


"Pre-treatment," "Pre-Patient" … same buzzword! I guess Accenture is trying to be pharm.'s "Precogs".

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

inVibe Voice-Powered Healthcare Insights vs. Traditional Qualitative Research

inVibe Voice-Powered Healthcare Insights vs. Traditional Qualitative Research | Pharmaguy's Insights Into Drug Industry News | Scoop.it

Over the last decade, the market research industry has been swept up in a race to the bottom. The rapid adoption of new technologies and ease of access to self-serve research platforms, delivering on the promise of speed and lower cost, has compromised the quality of the data upon which important, and often expensive, decisions are predicated.

 

Gaining that context — listening to the “voice” of the patient or target — gives rise to the actionable insights needed for market success of a product, service or campaign. However, traditional listening approaches in market research — focus groups, interviews, ethnography — are slow and expensive undertakings and each, for all their rigor and discipline, have limitations.

 

Often, web-based research services attempt to pass open-field text boxes off as qualitative research capabilities. However, it can be argued that this is an effort to force a qualitative response from a quantitative method and the data from open-field text boxes can be frustratingly limited, resulting in lackluster, and sometimes even erroneous, outcomes.

 

To define the value of voice response data capture over the readily available open-field text format available via most web-based survey services, inVibe analyzed three studies that employed both voice response and open-field data capture methods. inVibe compared the typed responses from survey formats to the transcripts produced using their proprietary voice response insights platform. Text composition statistics and four different grade-level readability measures were used to compare data quality between these two instruments.

 

The data from this analysis strongly supports the premise that use of an automated platform that seamlessly enables voice data collection can be an efficient and effective tool for conducting comprehensive qualitative market research.

 

Download the white paper here.

 

The inVibe voice response system was used to survey patients about direct-to-consumer off-label drug promotion. Learn more about that and listen to some responses here: http://sco.lt/5cDpez

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Pharmaguy's Getting to Know You Twitter Survey

Pharmaguy's Getting to Know You Twitter Survey | Pharmaguy's Insights Into Drug Industry News | Scoop.it

Please take a minute to tell me a bit about yourself. Your answers will help me understand what's important to you so that my tweets are more relevant to you.

 

Your response is confidential and it is not required that you provide personal information.

 

However, the last page allows you to identify yourself so that I may contact you (with your permission) and add you to my database of contacts (also with your permission). I am often asked to recommend people for jobs, speaking engagements, and other career-helpful activities and you could be one of these people!

 

Please click here to start.

 

P.S. At the end of the survey, you will find a link to a view of the de-identified summary of responses to date. Personal information and comments are not included in this summary.

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Survey: Few Gen-Xers & Baby Boomers Trust #Pharma Paid Celebrity Endorsements

Survey: Few Gen-Xers & Baby Boomers Trust #Pharma Paid Celebrity Endorsements | Pharmaguy's Insights Into Drug Industry News | Scoop.it

Millennials were the most likely generation to respond to pharma advertising and visit a related website, a new survey from Makovsky/Kelton “Pulse of Online Search” survey found. Just over half (51%) of millennials would be motivated to visit a pharma site, compared to 36% of Gen-Xers and 26% of baby boomers.


Although online marketing has expanded, TV remained the most influential medium among millennials. Just over a quarter of those surveyed said they would respond most to TV advertising.
Celebrity endorsements, however, carried little weight. Only 22% of millennials and 13% of participants overall trusted celebrity endorsements of pharmaceuticals.


Although it may seem counterintuitive, millennials proved very responsive to television compared to other mediums. The youngest generation was also the most likely to ask for a medication for name when they visited the doctor’s office, with 69% reporting they would be likely to do so.

Pharma Guy's insight:

See more results form the Makovsk/Kelton Survey: http://bit.ly/MakovskySurvey 

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Should the Tax Deduction for DTC Advertising Expenses be Eliminated?

Should the Tax Deduction for DTC Advertising Expenses be Eliminated? | Pharmaguy's Insights Into Drug Industry News | Scoop.it

69% of respondents to the Pharma Marketing News Future of DTC Survey said "yes" (39%) or "maybe, it depends" (30%) when asked if the DTC business tax deduction should be eliminated (see chart).

 

You can take this survey here and give you opinion about this and other issues that will have an imppact on the future of DTC. Afterward, you can view a summary of the latest, de-identified results.

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

How Effective is TV vs Online DTC Advertising? FDA Wants to Know.

How Effective is TV vs Online DTC Advertising? FDA Wants to Know. | Pharmaguy's Insights Into Drug Industry News | Scoop.it

FDA is proposing a"National Direct-to-Consumer Advertising Survey" of 1765 and soliciting comments on its plan in the Federal Register [Docket No. FDA-2016-N-0544].

Recall that the FDA is currently doing or planning at least two other studies of Direct-to-Consumer (DTC) advertising:


  1. "Spousal Influence on Consumer Understanding of and Response to Direct-To-Consumer Prescription Drug Advertisements"; FDA-2014-N-1819). For more on that, read "Does Your Spouse Influence Your DTC Viewing Experience?"), and 
  2. "Experimental Study of Direct-to-Consumer Promotion Directed at Adolescents" (FR # FDA-2013-N-1151). For more on that, read this Pharma Marketing News article.


FDA surveyed patients about their experiences with and attitudes toward DTC advertising in 2002 (here). Why is FDA proposing the new study now? Find out here.

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

Some - Not All - Americans Hate Pharma More Than Ever, Says Gallup Poll

Some - Not All - Americans Hate Pharma More Than Ever, Says Gallup Poll | Pharmaguy's Insights Into Drug Industry News | Scoop.it

The story came to me via Google Alerts: "People in the US Hate Big Pharma, Study Finds." At first, my reaction was Duh! Nothing to see here, considering all the pushback from physicians and other stakeholders (including patients?) regarding high drug prices.


I clicked through anyway to the story on teleSUR (a Latin American multimedia platform - how does it get included in Google Alerts whereas this blog does not?). Perhaps something was lost in translation - perhaps a better translation would have been the title I'm using for this post. 


In any case, the chart above shows trending data direct from Gallup (here), which surveyed 1,011 U.S. adults in in the first week of August 2015 via telephone.


IMHO, the saw-tooth trend indicates a love-hate relationship. Last year (2014) pharma gained respect, this year it lost it - but not as much as in most previous years. 

Also, there are some segments of the population that have a positive view of the pharmaceutical industry. Can you guess who?


Find out here...

more...
No comment yet.
Scooped by Pharma Guy
Scoop.it!

The birth of the healthcare consumer: Growing demands for choice, engagement, and experience

The birth of the healthcare consumer: Growing demands for choice, engagement, and experience | Pharmaguy's Insights Into Drug Industry News | Scoop.it

There’s a new boss in U.S. healthcare: the consumer. That’s the key finding in an extensive survey of 2,339 U.S. residents by Strategy&. The research paints a clear picture of a population displeased with its overall healthcare experience — and with rising expectations for transparency, value, and customer service, as well as a willingness to seek healthcare services from less traditional sources. The healthcare market as we know it is being upended, and the consumer is in the driver’s seat.

Pharma Guy's insight:


Not sure how this applies to pharma industry.

more...
No comment yet.